文献速递妇科

妇科手术后阿片类药物的使用与误用

Use and Misuse of Opioids After Gynecologic Surgical Procedures.
PubMed 文献 · Obstet Gynecol · 2019-01-01

基于MarketScan数据库的回顾性队列研究纳入2009至2016年接受妇科大、小手术的729625例患者,60.0%获得围手术期阿片类处方,获得处方者中新发持续性阿片使用总体为6.8%,且不同术式间存在差异。

要点

  • 729625例妇科手术患者中60.0%获得围手术期阿片类处方,各术式从宫腔刮宫术36.7%到微创子宫切除术79.5%不等。
  • 获得围手术期阿片类处方者中新发持续性阿片使用总体为6.8%,各术式间差异有统计学意义(P<.001)。
  • 获得处方者中新发持续性阿片使用率由2010年7.0%降至2016年5.5%(P<.001)。

核心结论

  • 妇科大、小手术后新发持续性阿片使用率较高,作者称其为substantial(相当可观)。

研究设计与样本

  • 纳入2009至2016年接受妇科大、小手术的女性。
  • 新发持续性阿片使用定义为术后90至180天获得一次及以上阿片类处方,且期间无其他操作或麻醉。
  • 采用多变量模型分析临床特征与任何阿片使用及新发持续性使用之间的关联。

主要发现

  • 共识别729625例患者,总体60.0%获得围手术期阿片类处方。
  • 获得阿片类处方的比例从宫腔刮宫术36.7%到微创子宫切除术79.5%不等。
  • 获得围手术期阿片类处方者中新发持续性阿片使用总体为6.8%。
  • 各术式新发持续性阿片使用率:子宫肌瘤剔除术4.8%、微创子宫切除术6.6%、开腹子宫切除术6.7%、子宫内膜消融术6.3%、输卵管结扎术7.0%、宫腔刮宫术7.2%(P<.001)。
  • 多变量模型中宫腔刮宫术与子宫内膜消融术患者的新发持续性阿片使用风险最高;较年轻患者、Medicaid受助者及合并抑郁、焦虑、物质使用障碍者更常见新发持续性阿片使用(P均<.001)。

关键数值与推荐

  • 获得阿片类处方者中新发持续性阿片使用率由2010年7.0%降至2016年5.5%(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the rate of opioid use for gynecologic surgical procedures and to investigate persistent opioid use among those women who received an initial opioid prescription. METHODS: A retrospective cohort study using the MarketScan database was performed. MarketScan is a claims-based data source that captures claims from more than 50 million privately insured patients and 6 million Medicaid enrollees from 12 states. We identified women who underwent major and minor gynecologic surgery from 2009 to 2016. Among women who received an opioid prescription, new persistent opioid use was defined as receipt of one or more opioid prescriptions from 90 to 180 days after surgery with no intervening additional procedures or anesthesia. Multivariable models were used to examine associations between clinical characteristics and any use and new persistent use of opioids. RESULTS: A total of 729,625 patients were identified. Overall, 60.0% of patients received a perioperative opioid prescription. Receipt of an opioid prescription ranged from 36.7% in those who underwent dilation and curettage to 79.5% of patients who underwent minimally invasive hysterectomy. Among patients who received a perioperative opioid prescription, the rate of new persistent opioid use overall was 6.8%. The rate of new persistent opioid use was 4.8% for myomectomy, 6.6% for minimally invasive hysterectomy, 6.7% for abdominal hysterectomy, 6.3% for endometrial ablation, 7.0% for tubal ligation, and 7.2% for dilation and curettage (P<.001). In a multivariable model, patients who underwent dilation and curettage and endometrial ablation were at highest risk for new persistent opioid use. Younger patients, Medicaid recipients, and patients with depression, anxiety, and substance use disorder more commonly had new persistent opioid use (P<.001 for all). Among women who received an opioid prescription, the rate of new persistent opioid use decreased over time from 7.0% in 2010 to 5.5% in 2016 (P<.001). CONCLUSION: The rate of new persistent opioid use after major and minor gynecologic procedures is substantial.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Wright JD, Huang Y, Melamed A, et al. Use and Misuse of Opioids After Gynecologic Surgical Procedures. Obstet Gynecol. 2019. PMID: 31306333. doi:10.1097/AOG.0000000000003358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。